Literature DB >> 2999187

Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems.

S Harada, H Yoshiyama, N Yamamoto.   

Abstract

MT-4 cells, which are a human T-cell lymphotropic virus type I (HTLV-I)-positive cell line highly permissive to HTLV-III infection, were used to detect the biologically active virus. For quantitation of the virus, induction of HTLV-III-specific antigen(s) and inhibition of DNA synthesis in infected MT-4 cells were assessed by indirect immunofluorescence and by a proliferation assay measuring [3H]thymidine uptake, respectively. HTLV-III was fully inactivated by treatment at 56 degrees C for 30 min. It was not inactivated by treatment with fresh anti-HTLV-III-negative serum. Thus, these assay systems with MT-4 cells would be useful in further studies on acquired immune deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999187      PMCID: PMC271849          DOI: 10.1128/jcm.22.6.908-911.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Human serum lyses RNA tumour viruses.

Authors:  R M Welsh; N R Cooper; F C Jensen; M B Oldstone
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

2.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

3.  Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus.

Authors:  M A Koerper; L S Kaminsky; J A Levy
Journal:  Lancet       Date:  1985-02-02       Impact factor: 79.321

4.  Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.

Authors:  J J Goedert; M G Sarngadharan; M E Eyster; S H Weiss; A J Bodner; R C Gallo; W A Blattner
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

5.  Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

Authors:  D Klatzmann; F Barré-Sinoussi; M T Nugeyre; C Danquet; E Vilmer; C Griscelli; F Brun-Veziret; C Rouzioux; J C Gluckman; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

6.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.

Authors:  B Spire; D Dormont; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

9.  Human T-cell leukaemia virus is not lysed by human serum.

Authors:  H Hoshino; H Tanaka; M Miwa; H Okada
Journal:  Nature       Date:  1984 Jul 26-Aug 1       Impact factor: 49.962

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  11 in total

1.  Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell.

Authors:  J Gyotoku; M A el-Farrash; S Fujimoto; W T Germeraad; Y Watanabe; K Teshigawara; S Harada; Y Katsura
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

Review 2.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells.

Authors:  H Nakashima; S Harada; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

4.  Model for inactivation and disposal of infectious human immunodeficiency virus and radioactive waste in a BL3 facility.

Authors:  M C Stinson; M S Galanek; A M Ducatman; F X Masse; D R Kuritzkes
Journal:  Appl Environ Microbiol       Date:  1990-01       Impact factor: 4.792

5.  IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.

Authors:  L A Rogers; S M Forster; A J Pinching
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

6.  Quantifying the infectivity of human immunodeficiency virus.

Authors:  S P Layne; J L Spouge; M Dembo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).

Authors:  D C Montefiori; K Stewart; J M Ahearn; J Zhou; J Zhou
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody.

Authors:  D C Montefiori; J Zhou; D I Shaff
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

9.  High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge.

Authors:  Christopher T Campbell; Sean R Llewellyn; Thorsten Demberg; Thorsten Damberg; Ian L Morgan; Marjorie Robert-Guroff; Jeffrey C Gildersleeve
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  Thermostability of human immunodeficiency virus (HIV-1) in a liquid matrix is far higher than that of an ecotropic murine leukemia virus.

Authors:  H Yoshikura
Journal:  Jpn J Cancer Res       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.